Pulp NecrosisPhase 2/3NCT03849222
Evaluation the Effect of Using of Apical Matrix With Apexification Procedure on Apical Healing of Necrotic Immature Teeth
A Phase 2/3 study testing Apexification, MTA and Ca(OH)2 in people with Pulp Necrosis and Apexification, run by Al-Azhar University.
Trial summary
This study was conducted to evaluate the effect of the use of apical matrix, with Mineral Trioxide Aggregate (MTA) or calcium hydroxide Ca(OH)2 Apexification on apical healing and calcific barrier formation of immature teeth with non- vital pulp. Read more about this study
- Who is it for?
- Ages 8 to 16 yearsHealthy volunteers can take part
- Conditions the study is for
- Pulp Necrosis, Apexification
- What is being tested?
- Apexification, MTA and Ca(OH)2
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 32 participants
- Where
- No sites listed yet
- Study dates
- 20 Aug 2013to 1 Sep 2016
- Phase
- Phase 2/3
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 8 to 16 years
- All sexes
- Healthy volunteers accepted
- Child
Who may be able to join
- Immature permanent maxillary anterior teeth
- Non vital pulp
- 6-18 years old
- Half or more root length developed Restorable
- No internal or external root resorption
- No horizontal or vertical root fractures
- Fit and healthy patient
Who cannot join
- Mature
- Vital pulp
- <6 ,>18 years old
- Less than half of the root developed
- Non - restorable
- Root resorption
- Horizontal or vertical root fractures
- Patients with history of uncontrolled diabetes, immunosuppression, severe asthma Patients suffering from periodontal disease
About this study
Official title: Enhancement of Apexification Procedure Outcome of Non Vital Incompletely Formed Roots Using Apical Matrix
This study was conducted to evaluate the effect of the use of apical matrix, with Mineral Trioxide Aggregate (MTA) or calcium hydroxide Ca(OH)2 Apexification on apical healing and calcific barrier formation of immature teeth with non- vital pulp.
Read the detailed description
Conventional root canal filling procedures are challenging in cases of teeth with necrotic pulp, immature apices, and periapical lesions because of the absence of natural apical constriction and the presence of moisture contamination. In these cases, the risk of extrusion of the root filling materials and the difficulty in managing apical seals compromise the long-term outcome of treatment.
Management of immature teeth with non-vital pulp were confined to custom fitting the filling material, paste fills and apical surgery. The limited success enjoyed by these procedures resulted in significant interest in the phenomenon of establishment of an apical barrier like apexification or continued apical development. Apexification defined as a procedure to induce a calcified barrier in a root with an open apex and necrotic pulp Traditionally, the most commonly used material for apexification is Ca(OH)2 .Despite the high success rate of The long-term Ca(OH)2 apexification , there are several disadvantages to this technique; Length of time for induction of apical hard tissue barriers. Incomplete apical hard tissue barriers because of vascular inclusions.To avoid the challenges associated with long-term Ca(OH)2 apexification procedures, a non-surgical, one-step apexification using MTA as apical plug.
The major problem in cases of a wide open apex is the need to limit the apexification material at the apex, thus avoiding the extrusion of a large amount of material into the periodontal tissue. The use of a matrix is advisable since its placement in the area of bone destruction provides a base on which the sealing material can be packed .
This randomized controlled trial study was carried out to compare the clinical and radiographic outcome of Ca(OH)2 and MTA with or without internal matrix in non-vital immature maxillary incisors.
- Conditions
- Pulp Necrosis, Apexification
- Being tested
- Apexification, MTA, Ca(OH)2, Apical matrix
- Keywords
- Open apex, Immature teeth, Non vital pulp, Apical plug, Internal matrix
- Medical subject headings
- Dental Pulp Necrosis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
ApexificationProcedure or surgery
MTADrug
Also called Proroot MTA
Ca(OH)2Drug
Also called Ca(OH)2 dressing
Apical matrixDrug
Also called internal matrix
collagen membrane (Biocollagen; Bioteck:Turin, Italy)
| Study group | Role | What they receive |
|---|---|---|
| Ca(OH)2 Apexification | Active comparator | Apexification was performed with calcium hydroxide. calcium hydroxide dressing was applied directly against the open apex .The canals were back filled with Ca(OH)2 dressing, followed by proper coronal seal. Patients were recalled every 3, 6 and 12 months for evaluation clinically and radiographically. Once the calcific apical barrier was detected the root canals were then obturated and final restoration was done. Receives: Procedure: Apexification; Drug: Ca(OH)2 |
| Ca(OH)2 Apexification with apical matrix | Experimental | Treated by condensation of calcium hydroxide dressing against an internal matrix , a piece (4X4mm) of resorbable collagen membrane (Biocollagen; Bioteck:Turin, Italy) was gently compacted toward the apex before insertion of Ca(OH)2 dressing, followed by proper coronal seal. Patients were recalled every 3, 6 and 12 months for evaluation clinically and radiographically. Once the calcific apical barrier was detected the root canals were then obturated and final restoration was done. Receives: Procedure: Apexification; Drug: Ca(OH)2; Drug: Apical matrix |
| MTA Apexification | Active comparator | Apexification was performed with MTA as apical plug. A 3-5 mm thickness of MTA using a hand plugger was applied as apical plug and verified radiographically. Moist cotton pellet was placed over the MTA followed by application of coronal seal. After 48 h, the set of the MTA was checked and final obturation of the root canal was done Receives: Procedure: Apexification; Drug: MTA |
| MTA Apexification with apical matrix | Experimental | An internal (apical) matrix was used as a base for condensation of MTA apical plug, a pieces of (4X4mm) of resorbable collagen membrane (Biocollagen; Bioteck:Turin, Italy)were compacted toward the apex with premeasured suitable size schilder plugger. Moist cotton pellet was placed over the MTA followed by application of coronal seal. After 48 h, the set of the MTA was checked and final obturation of the root canal was done Receives: Procedure: Apexification; Drug: MTA; Drug: Apical matrix |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in pain on percussion
Assessed by tapping the tooth with the back of the mirror (Present or absent) binary outcome
Measured: baseline, 3 months, 6 months, and 12 months
Change in swelling and/or sinus
Assessed by visual examination of labial vestibule.The presence of swelling or sinus reported by a binary question yes/no
Measured: baseline, 3 months, 6 months, and 12 months
Change in periapical pathosis
Change in periapical bone density on follow up radiographs to assess the healing process
Measured: 12 months
Secondary outcomes (2)
presence of a calcified apical barrier or not
Teeth will be reviewed clinically and radiographically in order to detect the calcific barrier formation
Measured: 3, 6 and 12 months
Periapical Lesion scored with periapical index ( PAI)
Radio graphically The periapical index provides an ordinal scale of 5 scores ranging from ''healthy'' to ''severe periodontitis with exacerbating features''. (1) Normal periapical structures. (2) Small changes in bone structure. (3) Changes in bone structure with some diffuse mineral loss.(4) Periodontitis with well-defined radiolucent area. (5) Severe periodontitis with exacerbating features. (1, 2: healthy and 3, 4, 5: pathological).baseline, 3 months, 6 months, and 12 months
Measured: 12 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted21 Feb 2019
- Study start20 Aug 2013
- Primary completion20 Apr 2016
- Study completion1 Sep 2016
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Pulp NecrosisStudies of the same condition, open and under way.
- More trials run by Al-Azhar UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 2/3
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- participants are allocated at random to receive one of 4 interventions according to the research plan.
- Masking
- Double blind
- Who is masked
- Participant, Outcomes assessor
- Enrolment
- 32 participants (actual)
Sponsor and investigators
- Lead sponsor
- Al-Azhar University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Maha A Elhussiny , Phd, Al-Azhar University
- Investigators
- Mervat IB Fawzy, Professor, Study director, Professor of Endodontics AL-Azhar university
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03849222
- Sponsor's protocol ID
- REC 61
- Status last verified
- Feb 2019
- First submitted
- 4 Jan 2019
- Last updated
- 21 Feb 2019
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 21 Feb 2019. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Enhancement of Apexification Procedure Outcome of Non Vital Incompletely Formed Roots Using Apical Matrix
- ClinicalTrials.gov ID
- NCT03849222
- Acronym / sponsor ID
- REC 61
- Conditions
- Pulp Necrosis, Apexification
- Keywords
- Open apex, Immature teeth, Non vital pulp, Apical plug, Internal matrix
- Phase
- Phase 2/3
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 32 participants (actual)
- Lead sponsor
- Al-Azhar UniversityUniversity, hospital or other
- Study start
- 20 Aug 2013 (actual)
- Primary completion
- 20 Apr 2016 (actual)
- Study completion
- 1 Sep 2016 (actual)
- First posted
- 21 Feb 2019 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study was conducted to evaluate the effect of the use of apical matrix, with Mineral Trioxide Aggregate (MTA) or calcium hydroxide Ca(OH)2 Apexification on apical healing and calcific barrier formation of immature teeth with non- vital pulp.
Detailed description
Conventional root canal filling procedures are challenging in cases of teeth with necrotic pulp, immature apices, and periapical lesions because of the absence of natural apical constriction and the presence of moisture contamination. In these cases, the risk of extrusion of the root filling materials and the difficulty in managing apical seals compromise the long-term outcome of treatment.
Management of immature teeth with non-vital pulp were confined to custom fitting the filling material, paste fills and apical surgery. The limited success enjoyed by these procedures resulted in significant interest in the phenomenon of establishment of an apical barrier like apexification or continued apical development. Apexification defined as a procedure to induce a calcified barrier in a root with an open apex and necrotic pulp Traditionally, the most commonly used material for apexification is Ca(OH)2 .Despite the high success rate of The long-term Ca(OH)2 apexification , there are several disadvantages to this technique; Length of time for induction of apical hard tissue barriers. Incomplete apical hard tissue barriers because of vascular inclusions.To avoid the challenges associated with long-term Ca(OH)2 apexification procedures, a non-surgical, one-step apexification using MTA as apical plug.
The major problem in cases of a wide open apex is the need to limit the apexification material at the apex, thus avoiding the extrusion of a large amount of material into the periodontal tissue. The use of a matrix is advisable since its placement in the area of bone destruction provides a base on which the sealing material can be packed .
This randomized controlled trial study was carried out to compare the clinical and radiographic outcome of Ca(OH)2 and MTA with or without internal matrix in non-vital immature maxillary incisors.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, outcomes assessor)
- Number of arms
- 4
- Model description
- participants are allocated at random to receive one of 4 interventions according to the research plan.
| Arm | Type | Receives |
|---|---|---|
| Ca(OH)2 Apexification | Active comparator | Procedure: Apexification, Drug: Ca(OH)2Apexification was performed with calcium hydroxide. calcium hydroxide dressing was applied directly against the open apex .The canals were back filled with Ca(OH)2 dressing, followed by proper coronal seal. Patients were recalled every 3, 6 and 12 months for evaluation clinically and radiographically. Once the calcific apical barrier was detected the root canals were then obturated and final restoration was done. |
| Ca(OH)2 Apexification with apical matrix | Experimental | Procedure: Apexification, Drug: Ca(OH)2, Drug: Apical matrixTreated by condensation of calcium hydroxide dressing against an internal matrix , a piece (4X4mm) of resorbable collagen membrane (Biocollagen; Bioteck:Turin, Italy) was gently compacted toward the apex before insertion of Ca(OH)2 dressing, followed by proper coronal seal. Patients were recalled every 3, 6 and 12 months for evaluation clinically and radiographically. Once the calcific apical barrier was detected the root canals were then obturated and final restoration was done. |
| MTA Apexification | Active comparator | Procedure: Apexification, Drug: MTAApexification was performed with MTA as apical plug. A 3-5 mm thickness of MTA using a hand plugger was applied as apical plug and verified radiographically. Moist cotton pellet was placed over the MTA followed by application of coronal seal. After 48 h, the set of the MTA was checked and final obturation of the root canal was done |
| MTA Apexification with apical matrix | Experimental | Procedure: Apexification, Drug: MTA, Drug: Apical matrixAn internal (apical) matrix was used as a base for condensation of MTA apical plug, a pieces of (4X4mm) of resorbable collagen membrane (Biocollagen; Bioteck:Turin, Italy)were compacted toward the apex with premeasured suitable size schilder plugger. Moist cotton pellet was placed over the MTA followed by application of coronal seal. After 48 h, the set of the MTA was checked and final obturation of the root canal was done |
Who may qualify
- Ages
- 8 to 16 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child
Key inclusion criteria (7 listed)
- Immature permanent maxillary anterior teeth
- Non vital pulp
- 6-18 years old
- Half or more root length developed Restorable
- No internal or external root resorption
Key exclusion criteria (8 listed)
- Mature
- Vital pulp
- <6 ,>18 years old
- Less than half of the root developed
- Non - restorable
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Apexification | Procedure or surgery | Ca(OH)2 Apexification, Ca(OH)2 Apexification with apical matrix, MTA Apexification, MTA Apexification with apical matrix |
| MTAAlso: Proroot MTA | Drug | MTA Apexification, MTA Apexification with apical matrix |
| Ca(OH)2Also: Ca(OH)2 dressing | Drug | Ca(OH)2 Apexification, Ca(OH)2 Apexification with apical matrix |
| Apical matrixAlso: internal matrixcollagen membrane (Biocollagen; Bioteck:Turin, Italy) | Drug | Ca(OH)2 Apexification with apical matrix, MTA Apexification with apical matrix |
Primary outcome
Change in pain on percussion
Time frame: baseline, 3 months, 6 months, and 12 months
Assessed by tapping the tooth with the back of the mirror (Present or absent) binary outcome
Change in swelling and/or sinus
Time frame: baseline, 3 months, 6 months, and 12 months
Assessed by visual examination of labial vestibule.The presence of swelling or sinus reported by a binary question yes/no
Change in periapical pathosis
Time frame: 12 months
Change in periapical bone density on follow up radiographs to assess the healing process
2 secondary outcomes
presence of a calcified apical barrier or not
Time frame: 3, 6 and 12 months
Periapical Lesion scored with periapical index ( PAI)
Time frame: 12 months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 21 Feb 2019.
- Individual participant dataSharing planned: Undecided
Related trials for Pulp Necrosis
Not yet recruiting
Post-operative Pain and Clinical Outcome After Single-cone Obturation With a Calcium Silicate-based Versus Epoxy Resin Sealer
Post Operative Pain, Acute, Irreversible Pulpitis (Toothache)
Not yet recruiting
PRP-Assisted Regenerative Endodontics Versus Conventional Root Canal Treatment in Mature Necrotic Teeth
Pulp Necrosis, Apical Periodontitis
Not yet recruiting
Influence of Continuous Rotation Versus Reciprocation Motion of MG3 Blue Rotary File on Postoperative Pain and Intracanal Bacterial Reduction of Teeth With Necrotic Pulps.
Necrotic Pulps With no Apical Periodontitis
Not yet recruiting
Clinical and Inflammatory Outcomes of Regenerative Endodontic Treatment Using Injectable Platelet-Rich Fibrin in Mature Necrotic Teeth With Chronic Apical Periodontitis.
Chronic Apical Periodontitis, Pulp Necrosis
Recruiting
Conventional and Nano-Metronidazole Irrigation With/Without Activation in Necrotic Teeth With Apical Periodontitis
Pulp Necrosis, Apical Periodontitis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Mervat IB Fawzy, Professor study director
Professor of Endodontics AL-Azhar university
Questions about this trial
What is this clinical trial studying?
A Phase 2/3 study testing Apexification, MTA and Ca(OH)2 in people with Pulp Necrosis and Apexification, run by Al-Azhar University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 21 Feb 2019. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this combined phase mean?
Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.
Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in pain on percussion (time frame: baseline, 3 months, 6 months, and 12 months). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Feb 2019.